NYSEAMERICAN:AMPE - Ampio Pharmaceuticals Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$2.16 +0.50 (+30.12 %)
(As of 06/24/2018 08:34 AM ET)
Previous Close$2.16
Today's Range$1.67 - $2.55
52-Week Range$0.38 - $4.95
Volume10.24 million shs
Average Volume1.04 million shs
Market Capitalization$197.70 million
P/E RatioN/A
Dividend YieldN/A
Ampio Pharmaceuticals logoAmpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee; and Optina, an oral agent for the treatment of diabetic macular edema. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.

Receive AMPE News and Ratings via Email

Sign-up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity-965.03%
Return on Assets-151.95%


Outstanding Shares86,320,000

The Truth About Cryptocurrencies

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Frequently Asked Questions

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "AMPE."

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) posted its quarterly earnings data on Tuesday, February, 24th. The specialty pharmaceutical company reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.20) by $0.01. The specialty pharmaceutical company earned $0.02 million during the quarter. View Ampio Pharmaceuticals' Earnings History.

Are investors shorting Ampio Pharmaceuticals?

Ampio Pharmaceuticals saw a decrease in short interest in May. As of May 31st, there was short interest totalling 10,472,904 shares, a decrease of 6.6% from the May 15th total of 11,209,042 shares. Based on an average daily volume of 806,646 shares, the days-to-cover ratio is currently 13.0 days. Currently, 13.5% of the shares of the stock are short sold. View Ampio Pharmaceuticals' Current Options Chain.

Who are some of Ampio Pharmaceuticals' key competitors?

Who are Ampio Pharmaceuticals' key executives?

Ampio Pharmaceuticals' management team includes the folowing people:
  • Mr. Michael Macaluso, Founder, Chairman & CEO (Age 66)
  • Mr. Thomas E. Chilcott III, CFO & Sec. (Age 50)
  • Ms. Holli Cherevka, Chief Operating Officer (Age 35)
  • Dr. David Bar-Or M.D., Chief Scientific Officer & Director (Age 69)
  • Mr. Philip H. Coelho, Director (Age 74)

Has Ampio Pharmaceuticals been receiving favorable news coverage?

Headlines about AMPE stock have trended somewhat positive on Sunday, Accern reports. Accern ranks the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Ampio Pharmaceuticals earned a daily sentiment score of 0.07 on Accern's scale. They also gave headlines about the specialty pharmaceutical company an impact score of 46.91 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Ampio Pharmaceuticals' major shareholders?

Ampio Pharmaceuticals' stock is owned by a number of of retail and institutional investors. Top institutional investors include Millennium Management LLC (0.91%), Tibra Equities Europe Ltd (0.20%), Cypress Capital Management LLC WY (0.20%), Prosight Management LP (0.13%), Noven Financial Group Inc. (0.12%) and Brighton Jones LLC (0.10%). View Institutional Ownership Trends for Ampio Pharmaceuticals.

Which institutional investors are selling Ampio Pharmaceuticals stock?

AMPE stock was sold by a variety of institutional investors in the last quarter, including Noven Financial Group Inc.. View Insider Buying and Selling for Ampio Pharmaceuticals.

Which institutional investors are buying Ampio Pharmaceuticals stock?

AMPE stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Tibra Equities Europe Ltd, Prosight Management LP, Element Capital Management LLC, A.R.T. Advisors LLC, Cypress Capital Management LLC WY and Brighton Jones LLC. View Insider Buying and Selling for Ampio Pharmaceuticals.

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $2.16.

How big of a company is Ampio Pharmaceuticals?

Ampio Pharmaceuticals has a market capitalization of $197.70 million.

How can I contact Ampio Pharmaceuticals?

Ampio Pharmaceuticals' mailing address is 373 Inverness Pkwy Ste 200, ENGLEWOOD, CO 80112-5898, United States. The specialty pharmaceutical company can be reached via phone at +1-720-4376500.

MarketBeat Community Rating for Ampio Pharmaceuticals (AMPE)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  81 (Vote Outperform)
Underperform Votes:  72 (Vote Underperform)
Total Votes:  153
MarketBeat's community ratings are surveys of what our community members think about Ampio Pharmaceuticals and other stocks. Vote "Outperform" if you believe AMPE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMPE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.